
Read More
This Multibagger Pharma Giant’s Subsidiary Becomes First Fully NABL Accredi...
Over the past year, the stock has delivered a return of 27.39 per cent, while the three-year return ...

Over the past year, the stock has delivered a return of 27.39 per cent, while the three-year return ...

The company reported a net income of Rs 8,552 crore, marking a 39.5 per cent YoY growth. Total sales...

Watch out for these stocks in Wednesday’s trading session!...

This pharma company stock went 8 per cent high, do you own it? ...

NSE Nifty 50 index plunged 0.25 per cent to close below 18,200 level while Sensex slipped 150 points...

The weakening global economic environment has spiked up the bond yields and dollar index, which fost...

At the time of the closing bell on Thursday, the markets eroded the day’s gains, ahead of the monthl...

On Wednesday, the benchmark indices remained under pressure post the repo rate hike. RBI hiked the k...

Due to the global sell-off, the Indian equity markets traded under pressure with Sensex rattling 1,4...

At noon on Thursday, the core equity indices i.e., Sensex and Nifty 50 fell sharply as the global ma...